EUVIMEDEUVIMED entdecken
Crossref

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Riccardo Prezzavento, Davide Capodanno iD

Thrombosis and Haemostasis · 08.07.2026

DOI: 10.1055/a-2901-6693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 08.07.2026. Verfasst von Riccardo Prezzavento und 1 weiteren Autor:innen. Beteiligte Einrichtung: A.O.U. Policlinico "G. Rodolico - San Marco", University of Catania, Cardiology Unit, Italy, Italy, Catania.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractPrasugrel and ticagrelor are potent oral P2Y12 inhibitors that carry a Class I recommendation for patients with acute coronary syndromes undergoing percutaneous coronary intervention, providing faster and more consistent platelet inhibition than clopidogrel. Despite identical guideline positioning, the optimal choice between the two agents has long remained unsettled, largely because head-to-head randomized data were scarce and the agents were assumed to be clinically interchangeable. That assumption is now substantially challenged by two large randomized trials (ISAR-REACT 5 and TUXEDO-2) whose convergent findings consistently point in the same direction. Here, we argue that the accumulated pharmacological and clinical evidence builds a coherent, mechanistically grounded case for the preferential use of prasugrel in appropriately selected patients, and that persisting therapeutic inertia against this drug is no longer scientifically defensible.

Autor:innen und Institutionen

  • A.O.U. Policlinico "G. Rodolico - San Marco", University of Catania, Cardiology Unit, Italy, Italy, Catania.

ORCID-Profile: Davide Capodanno

Zitieren

APA

Prezzavento, R., & Capodanno, D. (2026). Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2901-6693

Vancouver

Prezzavento R, Capodanno D. Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2901-6693

BibTeX
@article{Prezzavento2026,
  author = {Prezzavento, Riccardo and Capodanno, Davide},
  title = {Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2901-6693}
}
Kostenlos starten →